Enterprise Ireland congratulates client company Neuravi, an Irish medical technology company which develops innovative devices for stroke therapy, on the announcement today that it has been acquired by Johnson & Johnson.
The company’s innovative EmboTrap Revascularization Platform device captures and removes clots from blood vessels and restores bloodflow and helps reduce the long-term effects of stroke.
Enterprise Ireland, the state agency responsible for the development of innovative Irish companies was an early investor in the company and has worked closely with Galway based Neuravi to invest in and support their ongoing research and innovation activity.
It is anticipated that the operations will continue and expand from its Galway base. Neuravi will continue to play an important role in the development of the Irish medtech innovation ecosystem which employs approximately 40,000 people in Ireland.
Techies Go Green, the business sustainability network, has launched new research showing that 69% of…
Jobs Expo, the Irish recruitment exhibition brand that has brought more than 80,000 jobseekers face…
Robot vacuum cleaners have moved on considerably in the last few years. Simply being able…
Latest guest post by Declan Goodman, who is a digital transformation consultant, speaker and creator…
Guest post by Jimmy Cockerton, who is the author of No Risk Side Hustle: BUILD…
Bitcoin closed August 2026 near $78,500–$79,000 after a sharp monthly rebound. The move from the…
Irish Tech News are Ireland’s No. 1 Online Tech Publication and often Ireland’s No.1 Tech Podcast too.
You can find hundreds of fantastic previous episodes and subscribe using whatever platform you like via our Anchor.fm page here: https://anchor.fm/irish-tech-news
If you’d like to be featured in an upcoming Podcast email us at Simon@IrishTechNews.ie now to discuss.
Irish Tech News have a range of services available to help promote your business. Why not drop us a line at Info@IrishTechNews.ie now to find out more about how we can help you reach our audience.
You can also find and follow us on Twitter, LinkedIn, Facebook, Instagram, TikTok and Snapchat.